-
1
-
-
80053184864
-
Nanomedicine in the European Commission policy for nanotechnology
-
Gabellieri C., Frima H. Nanomedicine in the European Commission policy for nanotechnology. Nanomedicine 2011, 7:519-520.
-
(2011)
Nanomedicine
, vol.7
, pp. 519-520
-
-
Gabellieri, C.1
Frima, H.2
-
2
-
-
73749083481
-
Global estimates of the prevalence of diabetes for 2010 and 2030
-
Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 4-14
-
-
Shaw, J.E.1
Sicree, R.A.2
Zimmet, P.Z.3
-
3
-
-
78651276631
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34:S62-S69.
-
(2011)
Diabetes Care
, vol.34
, pp. 62-69
-
-
-
4
-
-
84865026205
-
Multiple comorbid conditions among middle-aged and elderly hemophilia patients: prevalence estimates and implications for future care
-
Khleif A.A., Rodriguez N., Brown D., Escobar M.A. Multiple comorbid conditions among middle-aged and elderly hemophilia patients: prevalence estimates and implications for future care. J Aging Res 2011, 2011:985703.
-
(2011)
J Aging Res
, vol.2011
, pp. 985703
-
-
Khleif, A.A.1
Rodriguez, N.2
Brown, D.3
Escobar, M.A.4
-
5
-
-
38149042694
-
An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment
-
Marchetti P., Dotta F., Lauro D., Purrello F. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 2008, 146:4-11.
-
(2008)
Regul Pept
, vol.146
, pp. 4-11
-
-
Marchetti, P.1
Dotta, F.2
Lauro, D.3
Purrello, F.4
-
7
-
-
78649678999
-
Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils
-
Misra A., Singhal N., Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr 2010, 29:289S-301S.
-
(2010)
J Am Coll Nutr
, vol.29
-
-
Misra, A.1
Singhal, N.2
Khurana, L.3
-
8
-
-
0347319044
-
Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
-
Mangoni A.A., Jackson S.H.D. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004, 57:6-14.
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 6-14
-
-
Mangoni, A.A.1
Jackson, S.H.D.2
-
9
-
-
0019429337
-
Insulin secretion in diabetes mellitus
-
Pfeifer M.A., Halter J.B., Porte D. Insulin secretion in diabetes mellitus. Am J Med 1981, 70:579-588.
-
(1981)
Am J Med
, vol.70
, pp. 579-588
-
-
Pfeifer, M.A.1
Halter, J.B.2
Porte, D.3
-
10
-
-
66649084335
-
Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice
-
Tschen S.I., Dhawan S., Gurlo T., Bhushan A. Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 2009, 58:1312-1320.
-
(2009)
Diabetes
, vol.58
, pp. 1312-1320
-
-
Tschen, S.I.1
Dhawan, S.2
Gurlo, T.3
Bhushan, A.4
-
11
-
-
33845467504
-
Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP
-
Meier J.J., Kayed R., Lin C.Y., et al. Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab 2006, 291:E1317-E1324.
-
(2006)
Am J Physiol Endocrinol Metab
, vol.291
-
-
Meier, J.J.1
Kayed, R.2
Lin, C.Y.3
-
12
-
-
23744439083
-
Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
-
Gunton J.E., Kulkarni R.N., Yim S., et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122:337-349.
-
(2005)
Cell
, vol.122
, pp. 337-349
-
-
Gunton, J.E.1
Kulkarni, R.N.2
Yim, S.3
-
13
-
-
20044390365
-
Functional and molecular defects of pancreatic islets in human type 2 diabetes
-
Del Guerra S., Lupi R., Marselli L., et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005, 54:727-735.
-
(2005)
Diabetes
, vol.54
, pp. 727-735
-
-
Del Guerra, S.1
Lupi, R.2
Marselli, L.3
-
14
-
-
33644772589
-
Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients
-
Ostenson C.G., Gaisano H., Sheu L., Tibell A., Bartfai T. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 2006, 55:435-440.
-
(2006)
Diabetes
, vol.55
, pp. 435-440
-
-
Ostenson, C.G.1
Gaisano, H.2
Sheu, L.3
Tibell, A.4
Bartfai, T.5
-
15
-
-
38849135820
-
The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1
-
Brun T., Hu He K.H., Lupi R., et al. The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1. Hum Mol Genet 2008, 17:478-489.
-
(2008)
Hum Mol Genet
, vol.17
, pp. 478-489
-
-
Brun, T.1
Hu He, K.H.2
Lupi, R.3
-
16
-
-
34547702501
-
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
-
Lyssenko V., Lupi R., Marchetti P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117:2155-2163.
-
(2007)
J Clin Invest
, vol.117
, pp. 2155-2163
-
-
Lyssenko, V.1
Lupi, R.2
Marchetti, P.3
-
17
-
-
8744272467
-
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin
-
Marchetti P., Del Guerra S., Marselli L., et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004, 89:5535-5541.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5535-5541
-
-
Marchetti, P.1
Del Guerra, S.2
Marselli, L.3
-
18
-
-
67249096093
-
Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
-
Shu L., Matveyenko A.V., Kerr-Conte J., Cho J.H., McIntosh C.H., Maedler K. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 2009, 18:2299-2388.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 2299-2388
-
-
Shu, L.1
Matveyenko, A.V.2
Kerr-Conte, J.3
Cho, J.H.4
McIntosh, C.H.5
Maedler, K.6
-
19
-
-
71549166982
-
Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals
-
Nyblom H.K., Bugliani M., Fung E., et al. Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals. J Proteome Res 2009, 8:5650-5656.
-
(2009)
J Proteome Res
, vol.8
, pp. 5650-5656
-
-
Nyblom, H.K.1
Bugliani, M.2
Fung, E.3
-
20
-
-
33847012626
-
Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets
-
Ritzel R.A., Meier J.J., Lin C.Y., Veldhuis J.D., Butler P.C. Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes 2007, 56:65-71.
-
(2007)
Diabetes
, vol.56
, pp. 65-71
-
-
Ritzel, R.A.1
Meier, J.J.2
Lin, C.Y.3
Veldhuis, J.D.4
Butler, P.C.5
-
21
-
-
66749146650
-
MicroRNAs in diabetes: tiny players in big disease
-
Pandey A.K., Agarwal P., Kaur K., Datta M. MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem 2009, 23:221-232.
-
(2009)
Cell Physiol Biochem
, vol.23
, pp. 221-232
-
-
Pandey, A.K.1
Agarwal, P.2
Kaur, K.3
Datta, M.4
-
22
-
-
30044434823
-
MicroRNAs: 'ribo-regulators' of glucose homeostasis
-
Gauthier B.R., Wollheim C.B. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med 2006, 12:36-38.
-
(2006)
Nat Med
, vol.12
, pp. 36-38
-
-
Gauthier, B.R.1
Wollheim, C.B.2
-
23
-
-
33644982043
-
MicroRNAs as therapeutic targets
-
Czech M.P. MicroRNAs as therapeutic targets. The New Eng J Med 2006, 354:1194-1195.
-
(2006)
The New Eng J Med
, vol.354
, pp. 1194-1195
-
-
Czech, M.P.1
-
24
-
-
79952795269
-
Diabetes mellitus, a microRNA-related disease?
-
Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA-related disease?. Transl Res 2011, 157:253-264.
-
(2011)
Transl Res
, vol.157
, pp. 253-264
-
-
Guay, C.1
Roggli, E.2
Nesca, V.3
Jacovetti, C.4
Regazzi, R.5
-
25
-
-
77953439038
-
DNA microarray analysis of whole blood cells and insulin-sensitive tissues reveals the usefulness of blood RNA profiling as a source of markers for predicting type 2 diabetes
-
Hayashi Y., Kajimoto K., Iida S., et al. DNA microarray analysis of whole blood cells and insulin-sensitive tissues reveals the usefulness of blood RNA profiling as a source of markers for predicting type 2 diabetes. Biol. Pharm. Bull. 2010, 33:1033-1042.
-
(2010)
Biol. Pharm. Bull.
, vol.33
, pp. 1033-1042
-
-
Hayashi, Y.1
Kajimoto, K.2
Iida, S.3
-
26
-
-
80052433997
-
Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport
-
Ohtsubo K., Chen M.Z., Olefsky J.M., Marth J.D. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 2011, 17:1067-1076.
-
(2011)
Nat Med
, vol.17
, pp. 1067-1076
-
-
Ohtsubo, K.1
Chen, M.Z.2
Olefsky, J.M.3
Marth, J.D.4
-
27
-
-
0035808264
-
Anti-amyloidogenic activity of tetracyclines: studies in vitro
-
Forloni G., Colombo L., Girola L., Tagliavini F., Salmona M. Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett 2001, 487:404-407.
-
(2001)
FEBS Lett
, vol.487
, pp. 404-407
-
-
Forloni, G.1
Colombo, L.2
Girola, L.3
Tagliavini, F.4
Salmona, M.5
-
28
-
-
78649817896
-
A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles
-
Tran H.N.A., Sousa F., Moda F., et al. A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles. Nanoscale 2010, 2:2724-2732.
-
(2010)
Nanoscale
, vol.2
, pp. 2724-2732
-
-
Tran, H.N.A.1
Sousa, F.2
Moda, F.3
-
30
-
-
36248965689
-
Current challenges in non-invasive insulin delivery systems: a comparative review
-
Khafagy el-S, Morishita M., Onuki Y., Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 2007, 59:1521-1546.
-
(2007)
Adv Drug Deliv Rev
, vol.59
, pp. 1521-1546
-
-
Khafagy, E.-S.1
Morishita, M.2
Onuki, Y.3
Takayama, K.4
-
31
-
-
73549111762
-
Challenges and advances in nanoparticle-based oral insulin delivery
-
Ramesan R.M., Sharma C.P. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev Med Devices 2009, 6:665-676.
-
(2009)
Expert Rev Med Devices
, vol.6
, pp. 665-676
-
-
Ramesan, R.M.1
Sharma, C.P.2
-
32
-
-
77957285711
-
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats
-
Sharma G., Wilson K., van der Walle C.F., Sattar N., Petrie J.R., Ravi Kumar M.N. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm 2010, 76:159-169.
-
(2010)
Eur J Pharm Biopharm
, vol.76
, pp. 159-169
-
-
Sharma, G.1
Wilson, K.2
van der Walle, C.F.3
Sattar, N.4
Petrie, J.R.5
Ravi Kumar, M.N.6
-
33
-
-
79954628593
-
Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery
-
Makhlof A., Tozuka Y., Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011, 42:445-451.
-
(2011)
Eur J Pharm Sci
, vol.42
, pp. 445-451
-
-
Makhlof, A.1
Tozuka, Y.2
Takeuchi, H.3
-
34
-
-
78650710879
-
Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin
-
Zhang Y., Wei W., Lv P., Wang L., Ma G. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm 2011, 77:11-19.
-
(2011)
Eur J Pharm Biopharm
, vol.77
, pp. 11-19
-
-
Zhang, Y.1
Wei, W.2
Lv, P.3
Wang, L.4
Ma, G.5
-
35
-
-
80052599281
-
Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin
-
Elsayed A., Al-Remawi M., Qinna N., Farouk A., Al-Souod K.A., Badwan A.A. Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin. AAPS PharmSciTech 2011, 12:958-964.
-
(2011)
AAPS PharmSciTech
, vol.12
, pp. 958-964
-
-
Elsayed, A.1
Al-Remawi, M.2
Qinna, N.3
Farouk, A.4
Al-Souod, K.A.5
Badwan, A.A.6
-
36
-
-
34250835820
-
Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin
-
Bhumkar D.R., Joshi H.M., Sastry M., Pokharkar V.B. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 2007, 24:1415-1426.
-
(2007)
Pharm Res
, vol.24
, pp. 1415-1426
-
-
Bhumkar, D.R.1
Joshi, H.M.2
Sastry, M.3
Pokharkar, V.B.4
-
37
-
-
79954420700
-
Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents
-
Chaudhury A., Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 2011, 12:10-20.
-
(2011)
AAPS PharmSciTech
, vol.12
, pp. 10-20
-
-
Chaudhury, A.1
Das, S.2
-
38
-
-
60849101842
-
Chitosan and its use in design of insulin delivery system
-
Wong T.W. Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formul 2009, 3:8-25.
-
(2009)
Recent Pat Drug Deliv Formul
, vol.3
, pp. 8-25
-
-
Wong, T.W.1
-
39
-
-
80054061227
-
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
-
Chen M.-C., Sonaje K., Chen K.-J., Sung H.-W. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 2011, 10.1016/j.biomaterials.2011.08.087.
-
(2011)
Biomaterials
-
-
Chen, M.-C.1
Sonaje, K.2
Chen, K.-J.3
Sung, H.-W.4
-
40
-
-
60149111908
-
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
-
Lai S.K., Wang Y.Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009, 61:158-171.
-
(2009)
Adv Drug Deliv Rev
, vol.61
, pp. 158-171
-
-
Lai, S.K.1
Wang, Y.Y.2
Hanes, J.3
-
41
-
-
42349105761
-
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
-
Wells J.M., Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008, 6:349-362.
-
(2008)
Nat Rev Microbiol
, vol.6
, pp. 349-362
-
-
Wells, J.M.1
Mercenier, A.2
-
42
-
-
33644836828
-
A case of anaphylaxis caused by the health food chitosan
-
Kato Y., Yagami A., Matsunaga K. A case of anaphylaxis caused by the health food chitosan. Arerugi 2005, 54(12):1427-1429.
-
(2005)
Arerugi
, vol.54
, Issue.12
, pp. 1427-1429
-
-
Kato, Y.1
Yagami, A.2
Matsunaga, K.3
-
43
-
-
58149091806
-
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity
-
Vaarala O., Atkinson M.A., Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008, 57:2555-2562.
-
(2008)
Diabetes
, vol.57
, pp. 2555-2562
-
-
Vaarala, O.1
Atkinson, M.A.2
Neu, J.3
-
44
-
-
0023411755
-
Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use
-
Brogden R.N., Heel R.C. Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. Drugs 1987, 34:350-371.
-
(1987)
Drugs
, vol.34
, pp. 350-371
-
-
Brogden, R.N.1
Heel, R.C.2
-
45
-
-
0027640323
-
Gastric mucosal blood flow and blood viscosity in patients with diabetes
-
511
-
Zhu L. Gastric mucosal blood flow and blood viscosity in patients with diabetes. Zhonghua Yi Xue Za Zhi 1993, 73:476-478. 511.
-
(1993)
Zhonghua Yi Xue Za Zhi
, vol.73
, pp. 476-478
-
-
Zhu, L.1
-
46
-
-
0022559689
-
Ageing and small-bowel mucosa: a morphometric study
-
Corazza G.R., Frazzoni M., Gatto M.R., Gasbarrini G. Ageing and small-bowel mucosa: a morphometric study. Gerontology 1986, 32:60-65.
-
(1986)
Gerontology
, vol.32
, pp. 60-65
-
-
Corazza, G.R.1
Frazzoni, M.2
Gatto, M.R.3
Gasbarrini, G.4
-
47
-
-
0029040056
-
The thickness of the mucus layer in different segments of the rats intestine
-
Szentkuti L., Lorenz K. The thickness of the mucus layer in different segments of the rats intestine. Histochem J 1995, 27:466-472.
-
(1995)
Histochem J
, vol.27
, pp. 466-472
-
-
Szentkuti, L.1
Lorenz, K.2
-
48
-
-
23344442120
-
Obesity alters gut microbial ecology
-
Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005, 102:11070-11075.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 11070-11075
-
-
Ley, R.E.1
Bäckhed, F.2
Turnbaugh, P.3
Lozupone, C.A.4
Knight, R.D.5
Gordon, J.I.6
-
49
-
-
77957264181
-
Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles
-
Woitiski C.B., Neufeld R.J., Veiga F., Carvalho R.A., Figueiredo I.V. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci 2010, 41:556-563.
-
(2010)
Eur J Pharm Sci
, vol.41
, pp. 556-563
-
-
Woitiski, C.B.1
Neufeld, R.J.2
Veiga, F.3
Carvalho, R.A.4
Figueiredo, I.V.5
-
50
-
-
74049130927
-
Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes
-
Damgé C., Socha M., Ubrich N., Maincent P. Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes. J Pharm Sci 2010, 99:879-889.
-
(2010)
J Pharm Sci
, vol.99
, pp. 879-889
-
-
Damgé, C.1
Socha, M.2
Ubrich, N.3
Maincent, P.4
-
51
-
-
84873066597
-
-
http://www.businesswire.com/portal/site/home/email/alert/%3FndmViewId=news_view%26newsLang=en%26newsId=20080409005647.
-
-
-
-
52
-
-
52749089075
-
Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes
-
Liu M.C., Riese R.J., Van Gundy K., Norwood P., Sullivan B.E., Schwartz P.F., et al. Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes. Eur Respir J 2008, 32:180-188.
-
(2008)
Eur Respir J
, vol.32
, pp. 180-188
-
-
Liu, M.C.1
Riese, R.J.2
Van Gundy, K.3
Norwood, P.4
Sullivan, B.E.5
Schwartz, P.F.6
-
53
-
-
79952317008
-
The influence of pulmonary surfactant on nanoparticulate drug delivery systems
-
Schleh C., Rothen-Rutishauser B., Kreyling W.G. The influence of pulmonary surfactant on nanoparticulate drug delivery systems. Eur J Pharm Biopharm 2011, 77:350-352.
-
(2011)
Eur J Pharm Biopharm
, vol.77
, pp. 350-352
-
-
Schleh, C.1
Rothen-Rutishauser, B.2
Kreyling, W.G.3
-
54
-
-
0035997333
-
Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles
-
Dyer A.M., Hinchcliffe M., Watts P., et al. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res 2002, 19:998-1008.
-
(2002)
Pharm Res
, vol.19
, pp. 998-1008
-
-
Dyer, A.M.1
Hinchcliffe, M.2
Watts, P.3
-
55
-
-
26844496437
-
Long-term clearance from small airways decreases with age
-
Svartengren M., Falk R., Philipson K. Long-term clearance from small airways decreases with age. Eur Respir J 2005, 26:609-615.
-
(2005)
Eur Respir J
, vol.26
, pp. 609-615
-
-
Svartengren, M.1
Falk, R.2
Philipson, K.3
-
56
-
-
0033035039
-
Physiological changes in respiratory function associated with ageing
-
Janssens J.P., Pache J.C., Nicod L.P. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999, 13:197-205.
-
(1999)
Eur Respir J
, vol.13
, pp. 197-205
-
-
Janssens, J.P.1
Pache, J.C.2
Nicod, L.P.3
-
57
-
-
17144404203
-
Animal models of diabetes mellitus
-
Rees D.A., Alcolado J.C. Animal models of diabetes mellitus. Diabet Med 2005, 22:359-370.
-
(2005)
Diabet Med
, vol.22
, pp. 359-370
-
-
Rees, D.A.1
Alcolado, J.C.2
-
58
-
-
77953770453
-
The future of mucosal immunology: studying an integrated system-wide organ
-
Gill N., Wlodarska M., Finlay B.B. The future of mucosal immunology: studying an integrated system-wide organ. Nat Immunol 2010, 11:558-560.
-
(2010)
Nat Immunol
, vol.11
, pp. 558-560
-
-
Gill, N.1
Wlodarska, M.2
Finlay, B.B.3
-
59
-
-
60149088354
-
Lessons from nature: "Pathogen-Mimetic" systems for mucosal nano-medicines
-
Mrsny R.J. Lessons from nature: "Pathogen-Mimetic" systems for mucosal nano-medicines. Drug Deliv Rev 2009, 61:172-192.
-
(2009)
Drug Deliv Rev
, vol.61
, pp. 172-192
-
-
Mrsny, R.J.1
-
60
-
-
34547638958
-
High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes
-
Huang C.J., Lin C.Y., Haataja L., et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007, 56:2016-2027.
-
(2007)
Diabetes
, vol.56
, pp. 2016-2027
-
-
Huang, C.J.1
Lin, C.Y.2
Haataja, L.3
-
61
-
-
79954580272
-
Current prospects for RNA interference-based therapies
-
Davidson B.L., McCray P.B. Current prospects for RNA interference-based therapies. Nat Rev Genet 2011, 12:329-340.
-
(2011)
Nat Rev Genet
, vol.12
, pp. 329-340
-
-
Davidson, B.L.1
McCray, P.B.2
-
62
-
-
33847018785
-
Oral insulin-mimetic compounds that act independently of insulin
-
García-Vicente S., Yraola F., Marti L., et al. Oral insulin-mimetic compounds that act independently of insulin. Diabetes 2007, 56:486-493.
-
(2007)
Diabetes
, vol.56
, pp. 486-493
-
-
García-Vicente, S.1
Yraola, F.2
Marti, L.3
-
63
-
-
79954609233
-
Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release
-
Wu Z., Zhang S., Zhang X., Shu S., Chu T., Yu D. Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release. J Pharm Sci 2011, 100:2278-2286.
-
(2011)
J Pharm Sci
, vol.100
, pp. 2278-2286
-
-
Wu, Z.1
Zhang, S.2
Zhang, X.3
Shu, S.4
Chu, T.5
Yu, D.6
-
64
-
-
78650146293
-
Multifunctional hybrid nanogel for integration of optical glucose sensing and self-regulated insulin release at physiological pH
-
Wu W., Mitra N., Yan E.C., Zhou S. Multifunctional hybrid nanogel for integration of optical glucose sensing and self-regulated insulin release at physiological pH. ACS Nano 2010, 4:4831-4839.
-
(2010)
ACS Nano
, vol.4
, pp. 4831-4839
-
-
Wu, W.1
Mitra, N.2
Yan, E.C.3
Zhou, S.4
-
65
-
-
79952926478
-
Water-in-oil microemulsions for effective transdermal delivery of proteins
-
Russell-Jones G., Himes R. Water-in-oil microemulsions for effective transdermal delivery of proteins. Expert Opin Drug Deliv 2011, 8:537-546.
-
(2011)
Expert Opin Drug Deliv
, vol.8
, pp. 537-546
-
-
Russell-Jones, G.1
Himes, R.2
-
66
-
-
77956224955
-
Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds
-
Hrynyk M., Martins-Green M., Barron A.E., Neufeld R.J. Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds. Int J Pharm 2010, 398:146-154.
-
(2010)
Int J Pharm
, vol.398
, pp. 146-154
-
-
Hrynyk, M.1
Martins-Green, M.2
Barron, A.E.3
Neufeld, R.J.4
|